Authors: Winchester, JF Brady, JA Ronco, C Yousha, E Smith, A Clemmer, J Muller, TE La Greca, G Levin, NW

Citation: Jf. Winchester et al., The role of middle molecules in uremia - Preliminary report of an international survey of nephrologists and scientists, CONTR NEPHR, 133, 2001, pp. 23-27

Authors: Winchester, JF Ronco, C Brady, JA Clemmer, J Muller, TE Davankov, V Tsyurupa, M Pavlova, L Pavlov, M Levin, NW

Citation: Jf. Winchester et al., History of sorbents in uremia, CONTR NEPHR, 133, 2001, pp. 131-139

Authors: Ronco, C Brendolan, A Winchester, JF Golds, E Clemmer, J Polaschegg, HD Muller, TE Davankov, V Tsyurupa, M Pavlova, L Pavlov, M La Greca, G Levin, NW

Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, CONTR NEPHR, 133, 2001, pp. 166-173

Authors: Winchester, JF Ronco, C Brady, JA Brendolan, A Davankov, V Tsyurupa, M Pavlova, L Pavlov, M Clemmer, J Polaschegg, HD Muller, TE La Greca, G Levin, NW

Citation: Jf. Winchester et al., Rationale for combined hemoperfusion/hemodialysis in uremia, CONTR NEPHR, 133, 2001, pp. 174-179

Authors: Winchester, JF Ronco, C Brady, JA Golds, E Clemmer, J Cowgill, LD Levin, NW

Citation: Jf. Winchester et al., Sorbent augmented dialysis: Minor addition or major advance in therapy?, BLOOD PURIF, 19(2), 2001, pp. 255-259

Authors: Ronco, C Brendolan, A Winchester, JF Golds, E Clemmer, J Polaschegg, HD Muller, TE La Greca, G Levin, NW

Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, BLOOD PURIF, 19(2), 2001, pp. 260-263